BACE-2 inhibitors for the treatment of metabolic disorders
- 专利权人:
- Novartis AG
- 发明人:
- Rueeger, Heinrich
- 申请号:
- AU2012206527
- 公开号:
- AU2012206527A1
- 申请日:
- 2012.01.13
- 申请国别(地区):
- AU
- 年份:
- 2013
- 代理人:
- 摘要:
- The present invention relates to the use of BACE-2 inhibitors and pharmaceutical compositions comprising BACE-2 inhibitors for treating metabolic disorders related to decreased β cell mass and/or function.
- 来源网站:
- 中国工程科技知识中心
相关发明人
相关专利
- BACE 2 INHIBITORS FOR THE TREATMENT OF METABOLIC DISORDERS
- ИНГИБИТОРЫ BACE-2 ДЛЯ ЛЕЧЕНИЯ МЕТАБОЛИЧЕСКИХ РАССТРОЙСТВ
- BACE-2 INHIBITORS FOR THE TREATMENT OF METABOLIC DISORDERS
- DÉRIVÉS DE L'OXAZINE ET LEUR UTILISATION POUR LE TRAITEMENT D'UNE MALADIE
- BACE-2 INHIBITORS FOR THE TREATMENT OF METABOLIC DISORDERS